Oventus Medical (ASX:OVN) Gross-Profit-to-Asset % : 4.65% (As of Dec. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Oventus Medical's annualized Gross Profit for the quarter that ended in Dec. 2021 was A$0.58 Mil. Oventus Medical's average Total Assets over the quarter that ended in Dec. 2021 was A$12.47 Mil. Therefore, Oventus Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2021 was 4.65%.

Oventus Medical Gross-Profit-to-Asset % Historical Data

The historical data trend for Oventus Medical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Gross-Profit-to-Asset % Chart

Oventus Medical Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Gross-Profit-to-Asset %

3.17

1.81

2.68

1.61

2.73

Oventus Medical Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
Gross-Profit-to-Asset %	Get a 7-Day Free Trial						1.64	1.52	3.98	2.28	4.65

Competitive Comparison of Oventus Medical's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Oventus Medical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oventus Medical's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Oventus Medical's Gross-Profit-to-Asset % falls into.

Oventus Medical Gross-Profit-to-Asset % Calculation

Oventus Medical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2021 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2021 )	/	( (Total Assets (A: Jun. 2020 )	+	Total Assets (A: Jun. 2021 ))	/ count )
	=	0.402	/	( (14.327	+	15.079)	/ 2 )
	=	0.402	/	14.703
	=	2.73 %

Oventus Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2021 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2021 )	/	( (Total Assets (Q: Jun. 2021 )	+	Total Assets (Q: Dec. 2021 ))	/ count )
	=	0.58	/	( (15.079	+	9.861)	/ 2 )
	=	0.58	/	12.47
	=	4.65 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2021) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Oventus Medical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Oventus Medical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oventus Medical (ASX:OVN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068

Website

https://www.o2vent.com

Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines